Surrey Heartlands

Joint Formulary & PAD

Chlorothiazide - Chronic lung disease (paediatric)

You are here : Home > Formulary Search > Chlorothiazide - Chronic lung disease (paediatric)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Oral solution
  • Oral suspension
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Restrictions / Comments :
Important
Unlicensed use. Initiation and stabilisation by specialist team before transfer of prescribing to primary care.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Chlorothiazide
Indication :
Chronic lung disease (paediatric)
Group Name :
Keywords :
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Chlorothiazide is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Chronic lung disease (paediatric).

  • No records returned.

Committee Recommendations (1)

06 Nov 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Initiation and stabilisation by specialist team before transfer of prescribing to primary care.